Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript


3%, gel

Diclofenac Sodium 3% w/w



Read all of this leaflet carefully before you start using this medicine.
• Keep this leaflet. You may need to read it again.
• If you have further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you personally and you should not pass it on to others.
It may harm them, even if their symptoms are the same as yours.
• If any of the side effects get serious, or if you notice any side effects not listed in this leaflet,
please tell your doctor or pharmacist.

In this leaflet:
1. What Solaraze is and what it is used for
2. Before you use Solaraze
3. How to use Solaraze
4. Possible side effects
5. How to store Solaraze
6. Further information

1. What Solaraze is and what it is used for
Solaraze is a non-steroidal anti-inflammatory dermatological gel. When applied to the skin, Solaraze
gel is used to treat a skin problem known as actinic or solar keratosis that is caused by long-term sun

2. Before you use Solaraze
Do not use Solaraze
• If you are allergic to diclofenac or any of the ingredients in Solaraze.
• If you have had an allergic reaction such as skin rash (nettle rash), breathing difficulties (wheezing)
or runny nose (allergic rhinitis) after taking aspirin or any other non-steroidal anti-inflammatory
• If you are in the final 3 months of your pregnancy.
Take special care with Solaraze
• The possibility of systemic side effects from application of Solaraze cannot be excluded if the
product is used on large areas of skin and over a prolonged period. Consult your doctor if:
- you have, or have had in the past, a stomach ulcer or bleeding from the stomach.
- you have heart, liver or kidney problems.
- you have any type of bleeding disorder or bruise very easily.
• Avoid sun exposure, including tanning salons, when using Solaraze. If skin reactions occur,
discontinue use.
• Do not apply to skin wounds, infected skin or dermatitis.
• Do not allow Solaraze to come into contact with your eyes or the inside of your nose or mouth and
do not swallow it. If Solaraze has accidentally been swallowed, consult a doctor immediately.
• Discontinue Solaraze and consult your doctor if you develop a wide-spread skin rash.
• After applying products containing diclofenac on the skin you can use a permeable (non-occlusive)
bandage. Do not use an airtight occlusive dressing.
Speak to your doctor if you are, or could be pregnant. Solaraze should be used with caution during the
first six months of pregnancy but must not be used during the last three months of pregnancy.
Consult your doctor if you are breastfeeding. Solaraze can be used whilst breastfeeding with caution but
should not be used on the breasts.
If you are pregnant, trying to get pregnant, or breastfeeding, and your doctor considers treatment
­appropriate, Solaraze must not be applied to an area of the skin larger than about a third of your body
and must not be used for longer than three weeks.
Ask your doctor or pharmacist for advice before taking or using any medicine.

3. How to use Solaraze

Solaraze is not suitable for children.
Use the gel as directed by your doctor.
Pierce the aluminium membrane across the tube opening with the cap before using.
Gently smooth a small amount of gel onto the skin over the area to be treated. The amount of gel
needed will vary depending upon the size of the area to be treated. Usually 0.5 grams of gel (about
the size of a pea) will be enough for one area (5cm x 5cm) but not more than 8 grams should be
used per day.
You can apply Solaraze twice daily unless your doctor tells you differently. You may notice a slight
cooling effect when you smooth the gel onto your skin.
The usual period of treatment is 60-90 days. Maximum effect has been seen with treatment times
closer to 90 days. Complete healing may not occur for up to a month after treatment has stopped.
Wash your hands after applying the gel, unless your hands are being treated.

If you use more Solaraze than you should
Remove the excess gel by washing with water.
If you forget to use Solaraze
Continue to apply as directed but do not apply twice as much to make up for the missed application.

4. Possible side effects


Like all medicines, Solaraze can have side effects although not everybody gets them.
If you have any of the following side effects, stop using Solaraze and contact your doctor as
soon as possible:
Skin rash (nettle rash); breathing difficulties (wheezing); swelling of the face; runny nose (allergic ­rhinitis).
These symptoms indicate that you may be allergic to Solaraze.


If any of the following common side effects are severe or last for more than a few days you should stop
using Solaraze and contact your doctor: itching, rash, skin redness, inflammation, contact dermatitis,
pain and blistering.
Other common side effects: (occur in between 1 and 10 out of every 100 patients)
Irritation or tingling at the site of treatment, conjunctivitis, allergy, a painful sensation when the skin
is touched, pins and needles, muscle stiffness, dermatitis, eczema, dry skin, swelling, rash (including
scaly or blistering), sagging of the skin, and skin ulcer.

Uncommon side effects: (occur in between 1 and 10 out of every 1,000 patients)
Eye pain, weeping/dry eyes, pain in the abdomen, diarrhoea, feeling sick, hair loss, facial swelling,
excessive bleeding or oily skin, a measles-like rash.
Rare side effects: (occur in between 1 and 10 out of every 10,000 patients)
Dermatitis with large blisters.
Very rare side effects: (occur in fewer than 1 in 10,000 patients)
Bleeding from your stomach, problems with your kidneys, breathing difficulties (asthma), infected
skin rash, skin sensitivity to sunlight.
Temporary hair discolouration at the application site has been reported. This is usually reversed on stopping treatment.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly (see below):
United Kingdom
Yellow Card Scheme, Website:
HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2, Tel: +353 1 6764971, Fax: +353 1 6762517,
Website:, e-mail:
By reporting side effects you can also provide more information on the safety of this medicine.

5. How to store Solaraze
Keep Solaraze out of the reach and sight of children.
Do not use after the expiry date (shown as ‘EXP’) on the tube and carton. The date refers to the last
date of that month.
Do not store above 25°C.
Shelf life after opening: 6 months.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These measures will help to protect the environment.

6. Further information
What Solaraze contains
• Each gram of gel contains the equivalent of 30mg diclofenac sodium (the active substance).
• The gel also contains sodium hyaluronate, benzyl alcohol, macrogol monomethyl ether 350 and
purified water.
What Solaraze looks like and contents of the pack
Solaraze gel is a clear, transparent, colourless or pale yellow gel packed in tubes containing 25 grams,
50 grams, 60 grams, 90 grams or 100 grams of product.
Marketing Authorisation Holder and Manufacturer
The marketing authorisation holder is Almirall, S.A., Ronda General Mitre, 151,
08022 Barcelona - Spain
The manufacturer is Almirall Hermal GmbH, Scholtzstrasse 3, D-21465 Reinbek, Germany.


Leaflet was last updated in March 2015

80009105 / UK/IRL / 0315

Marked trade name:



leaflet Solaraze 3% gel UK/IRL
Regulatory text number:



K. Schnau

Version number:



PDS 10883/85



Item Number:


PHES code


+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.